A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors

Clinical trial NCT00428597 · TERMINATED

Trial details

NCT number: NCT00428597
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Islet Cell Carcinoma, Pancreas

Start date: 2007-06-01
Primary completion: 2009-04-01
Enrollment: 171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.